Cascadian engages in the development of oncology products for the treatment of cancer... Read more
Cascadian engages in the development of oncology products for the treatment of cancer... Read more
CEO
Add
News
Dec 14, 2018
BioPortfolio
Cascadian Therapeutics: Cascadian Therapeutics Inc CASC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09112018 Prices from USD $250
Aug 16, 2018
BioPortfolio
Cascadian Therapeutics: Cascadian Therapeutics Inc CASC Financial and Strategic SWOT Analysis Review Report Updated 30052018 Prices from USD $125
Mar 29, 2018
Red Newswire
Cascadian Therapeutics: Cascadian Therapeutics Inc (CASC) Market Regional Briefing 2018 to 2022
Mar 16, 2018
BioPortfolio
Cascadian Therapeutics: Cascadian Therapeutics Inc CASC Financial and Strategic SWOT Analysis Review Report Updated 09032018 Prices from USD $300
Mar 16, 2018
Pharamceutical Technology
Cascadian Therapeutics: M&As this week: Seattle Genetics, Gryphon Investors, ChrysCapital
Mar 16, 2018
Zolmax News
Cascadian Therapeutics: Cascadian Therapeutics Inc (CASC) Sees Large Decrease in Short Interest
Mar 12, 2018
Pharamceutical Technology
Cascadian Therapeutics: Seattle Genetics finalises Cascadian Therapeutics acquisition
Feb 28, 2018
GeekWire
Cascadian Therapeutics: Cell therapies are giving Seattle an edge in biotech, driving three acquisitions in under a month
Feb 16, 2018
StreetInsider
Cascadian Therapeutics: Seattle Genetics (SGEN) Announces Expiration of HSR Waiting Period for Acquisition of Cascadian (CASC)
Feb 08, 2018
4-traders
Cascadian Therapeutics: Cascadian Therapeutics Inc (USA) : Today's Research Reports on Trending Tickers: Cascadian Therapeutics and UnitedHealth Group
Cascadian Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10